Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-α Agonist in Cognitive Impairment in Parkinson’s Disease: Behavioral, Biochemical, and PBPK Profile
Figure 5
(a) Simulated and observed fenofibric acid plasma concentration profiles for micronize suspension at dose strength of 27 mg/kg in the fasted state. (b) The concentration profile of fenofibric acid in the brain.
